Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-12-03

Clinical Trial Update: The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating how omega-3 fatty acid supplementation affects gene expression in people with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN